July 15, 2021
Nippon Shinyaku said on July 14 that it has filed three lawsuits against Sarepta Therapeutics in the US in a bid to defend the company’s intellectual property pertaining to technologies around its Duchenne muscular dystrophy (DMD) treatment Viltepso (viltolarsen). In...read more